These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7885392

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. DNA damage and repair induced by diazoacetyl derivatives of amino acids with different mechanism of cytotoxicity. Correlations with mutagenicity and carcinogenicity.
    Brambilla G, Cavanna M, Carlo P, Finollo R, Sciaba L, Parodi S, Bolognesi C.
    J Cancer Res Clin Oncol; 1979 May 14; 94(1):7-20. PubMed ID: 468901
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH, KARNOFSKY DA.
    Am J Physiol; 1958 Oct 14; 195(1):244-50. PubMed ID: 13583156
    [No Abstract] [Full Text] [Related]

  • 4. Effects of 5-azacytidine on somatic mutation in a soybean test system.
    Katoh Y, Maekawa M, Sano Y.
    Mutat Res; 1993 Jun 14; 300(1):49-55. PubMed ID: 7683768
    [Abstract] [Full Text] [Related]

  • 5. Mutagenic effects of nitropyrenes in a soybean test system.
    Katoh Y, Maekawa M, Sano Y.
    Mutat Res; 1994 Jan 14; 320(1-2):59-68. PubMed ID: 7506387
    [Abstract] [Full Text] [Related]

  • 6. Studies of DNA damage in rat pancreas and liver by 6-diazo-5-oxo-L-norleucine, ethyl diazoacetate and azaserine.
    Lilja HS, Longnecker DS, Curphey TJ, Daniel DS, Adams WE.
    Cancer Lett; 1981 Mar 14; 12(1-2):139-46. PubMed ID: 7272997
    [Abstract] [Full Text] [Related]

  • 7. Mutagenicity of D- and L-azaserine, 6-diazo-5-oxo-L-norleucine and N-(N-methyl-N-nitroso-carbamyl)-L-ornithine in the Salmonella test system.
    Staiano N, Everson RB, Cooney DA, Longnecker DS, Thorgeirsson SS.
    Mutat Res; 1980 Dec 14; 79(4):387-90. PubMed ID: 7003378
    [No Abstract] [Full Text] [Related]

  • 8. Soybean (Glycine max [L.] merrill) as a short-term assay for study of environmental mutagens. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Vig BK.
    Mutat Res; 1982 Nov 14; 99(3):339-47. PubMed ID: 6891026
    [Abstract] [Full Text] [Related]

  • 9. Effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) on somatic mutation in a soybean test system.
    Katoh Y, Maekawa M, Sano Y.
    Mutat Res; 1992 Jun 16; 279(4):239-43. PubMed ID: 1377778
    [Abstract] [Full Text] [Related]

  • 10. Effects on DON (6-diazo-5-oxo-L-norleucine) and azaserine on the sand-dollar embryo.
    KARNOFSKY DA, BEVELANDER G.
    Proc Soc Exp Biol Med; 1958 Jan 16; 97(1):32-7. PubMed ID: 13518172
    [No Abstract] [Full Text] [Related]

  • 11. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
    Lebedeva ZI, Kabanova EA, Berezov TT.
    Biull Eksp Biol Med; 1985 Dec 16; 100(12):696-8. PubMed ID: 4074870
    [Abstract] [Full Text] [Related]

  • 12. Isolation and characterization of a mutant Chinese hamster cell line resistant to the glutamine analog 6-diazo-5-oxo-L-norleucine.
    Kaufman ER.
    Somat Cell Mol Genet; 1985 Jan 16; 11(1):1-10. PubMed ID: 3856328
    [Abstract] [Full Text] [Related]

  • 13. Somatic crossing over in Glycine max (L.) Merrill: mutagenicity of sodium azide and lack of synergistic effect with caffeine and mitomycin C.
    Vig BK.
    Genetics; 1973 Oct 16; 75(2):265-77. PubMed ID: 4797661
    [Abstract] [Full Text] [Related]

  • 14. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
    Willis RC, Seegmiller JE.
    J Cell Physiol; 1977 Dec 16; 93(3):375-82. PubMed ID: 22551
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of genetic toxicity of 6-diazo-5-oxo-l-norleucine (DON).
    Kulkarni RM, Dakoulas EW, Miller KE, Terse PS.
    Toxicol Mech Methods; 2017 Sep 16; 27(7):518-527. PubMed ID: 28552037
    [Abstract] [Full Text] [Related]

  • 16. The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
    BUCHANAN JM.
    Tex Rep Biol Med; 1957 Sep 16; 15(1):148-53. PubMed ID: 13409287
    [No Abstract] [Full Text] [Related]

  • 17. Potential anti-cancer agents--II. A proposed mechanism for the anti-cancer action of L-azaserine and 6-diazo-5-oxo-L-norleucine.
    BAKER BR.
    Biochem Pharmacol; 1959 Sep 16; 2():161-7. PubMed ID: 13795976
    [No Abstract] [Full Text] [Related]

  • 18. 6-diazo-5-oxo-L-norleucine and azaserine as affinity inhibitors of glutamin(asparagin)ase.
    Lebedeva ZI, Kabanova EA, Berezov TT.
    Biochem Int; 1986 Mar 16; 12(3):413-20. PubMed ID: 3707592
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
    Lyons SD, Sant ME, Christopherson RI.
    J Biol Chem; 1990 Jul 05; 265(19):11377-81. PubMed ID: 2358467
    [Abstract] [Full Text] [Related]

  • 20. Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON).
    Rahman A, Smith FP, Luc PT, Woolley PV.
    Invest New Drugs; 1985 Jul 05; 3(4):369-74. PubMed ID: 4086244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.